Skip to main content
Book Chapter

Biosimilars in Deutschland und im europäischen Vergleich – Entwicklungen und Potenziale

  • Vogler S
  • Schneider P
  • Panteli D
  • et al.
Springer Berlin Heidelberg, (2019), 321-353
DOI: 10.1007/978-3-662-59046-1_8
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Vogler, S., Schneider, P., Panteli, D., & Busse, R. (2019). Biosimilars in Deutschland und im europäischen Vergleich – Entwicklungen und Potenziale. In Arzneiverordnungs-Report 2019 (pp. 321–353). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-59046-1_8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free